CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 96 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $126,000 | -21.7% | 10,692 | -51.6% | 0.05% | +14.0% |
| Q4 2016 | $161,000 | -80.5% | 22,111 | -85.4% | 0.04% | -71.5% |
| Q2 2016 | $824,000 | +115.1% | 150,979 | +84.6% | 0.15% | +174.5% |
| Q1 2016 | $383,000 | -82.5% | 81,788 | -81.3% | 0.06% | -76.6% |
| Q4 2015 | $2,183,000 | +82.5% | 438,371 | +37.9% | 0.24% | +104.3% |
| Q3 2015 | $1,196,000 | -36.7% | 317,997 | +1.2% | 0.12% | -37.5% |
| Q2 2015 | $1,888,000 | +2486.3% | 314,095 | +2315.0% | 0.18% | +2528.6% |
| Q1 2015 | $73,000 | -45.5% | 13,006 | -73.9% | 0.01% | -41.7% |
| Q3 2014 | $134,000 | -68.5% | 49,868 | -67.3% | 0.01% | -64.7% |
| Q2 2014 | $426,000 | -80.6% | 152,271 | -69.7% | 0.03% | -76.6% |
| Q1 2014 | $2,193,000 | +263.7% | 502,989 | +167.7% | 0.14% | +417.9% |
| Q4 2013 | $603,000 | +161.0% | 187,923 | +29.2% | 0.03% | +154.5% |
| Q3 2013 | $231,000 | -56.2% | 145,395 | -52.3% | 0.01% | -50.0% |
| Q2 2013 | $527,000 | – | 304,667 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,003,723 | $95,164,000 | 6.41% |
| TANAKA CAPITAL MANAGEMENT INC | 65,609 | $780,000 | 3.41% |
| S&T BANK/PA | 588,620 | $6,999,000 | 1.93% |
| Parallel Advisors, LLC | 1,405,895 | $16,716,000 | 1.35% |
| Matarin Capital Management, LLC | 623,915 | $7,418,000 | 1.15% |
| AJ WEALTH STRATEGIES, LLC | 668,020 | $7,943,000 | 1.08% |
| Capital Impact Advisors, LLC | 177,300 | $2,108,000 | 0.88% |
| Alambic Investment Management, L.P. | 29,547 | $351,000 | 0.85% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 332,436 | $3,953,000 | 0.79% |
| Spark Investment Management LLC | 116,400 | $1,383,000 | 0.74% |